TSX open
Loading markets…

Advertisement

Stocks

How Are Investors Reacting to argenx's Value Stock Comparison?

By Wealth Awesome -

Follow live quotes and coverage.

Stocks & ETFs:ARGX.US

Follow ARGX

Photos provided by Pexels

Investors are evaluating argenx NV in light of recent discussions about value stocks.

A recent article asked, "BMY or ARGX: Which Is the Better Value Stock Right Now?" This comes as argenx NV's stock has experienced fluctuations, prompting investors to reassess its current valuation and market position.

Advertisement

argenx NV ADR

ARGX.US

Full stock page →

ARGX.US

argenx NV ADR

Source:WealthAwesomeWealthAwesome
↑ $72.00 (8.56%)
120 day period
$775.03$916.97$1058.90Apr 15Jul 13Oct 5

Market cap

$57.16B

P/E

35.0x

52W high

$1072.75

52W low

$661.85

1W change

-6.11%

Beta

-0.03

Analyst Price Targets

Based on 11 analysts covering ARGX · as of Oct 5, 2026

📈

Wall Street analysts forecast ARGX stock price to rise 29.3% over the next 12 months.

Consensus

Buy

4.45 / 5.00

Avg. Target

C$1180.26

+29.3% Upside

Previously C$1180.17 on Oct 1, 2026

Current Price

C$912.87

Last close

Analyst Breakdown (11 analysts)

Strong Buy 7
Buy 2
Hold 2
Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on ARGX's historical volatility

HistoricalForecast68%95%
C$694.44C$825.41C$956.37C$1087.34C$1218.30C$1349.27TodayMay 28Aug 3Oct 5Nov 17Dec 31Feb 12

30-Day Vol

25.3%

Annualized

90-Day Vol

43.3%

Annualized

Trend (90d)

+16.5%

Annualized drift

90d Mean

C$968.42

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$931.02C$853.27 – C$1015.86
60 trading daysC$949.54C$839.36 – C$1074.17
90 trading daysC$968.42C$832.65 – C$1126.32

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

Investor takeaway: Investors should consider the implications of this value stock comparison as they analyze argenx's performance and outlook.

argenx's stock closed at US$914.90, down 0.69% for the day.

The stock's recent trading volume of 109,640 shares was 1.24 times its 20-day average, indicating increased interest despite the price drop.

Bull case

Analysts are optimistic about argenx, with an average target price suggesting a potential upside of 29% from the current level.

Bear case

However, the stock has declined over the past month and is trading below its 50-day moving average, signaling potential short-term challenges.

Market Performance Overview

Advertisement

On October 5, 2026, an article compared argenx (ARGX) to Bristol Myers Squibb (BMY) regarding value stock potential. In the latest trading session, argenx's stock closed at US$914.90, reflecting a decrease of 0.69% for the day. Over the past week, the stock has dropped by 6.11%, and in the last month, it has seen a decline of 11.64%. Year-to-date, however, the stock is up 8.68%, showing some resilience in the longer term.

Volume Trends and Market Sentiment

The latest trading volume for argenx was 109,640 shares, which is 1.24 times its 20-day average of 259,390 shares. This suggests an increase in trading activity, possibly driven by the recent discussions about value stocks. Despite the price decline, the higher volume indicates that investors are actively engaging with the stock, reflecting a mix of sentiment as they weigh the implications of the value comparison.

Looking Ahead: What to Watch

Investors should monitor argenx's upcoming performance relative to its 50-day moving average of US$956.72 and its 200-day moving average of US$851.23. Additionally, the average analyst target of US$1180.26 indicates a potential upside of 29%, suggesting that if the company can navigate current market challenges, it may offer long-term value. Keeping an eye on any further news or developments regarding its product pipeline and market position will also be crucial.


Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: October 6, 2026
Last Updated: October 6, 2026

Core portfolio

Awesome Portfolio™

14.8% a year since 2017, against 9.7% for the S&P/TSX Composite. Ten stocks, easy to manage. We update it once a month.

Annualized

+14.8%

Awesome Portfolio™

+9.7%

S&P/TSX

+5.0 pp better a year

Total return

+254%

Awesome Portfolio™

+134%

S&P/TSX

+119 pp better than the TSX

2017-07-31 to 2026-09-29, dividends reinvested, before fees and tax.

Awesome Portfolio™S&P/TSX CompositeCumulative return · 2017-07-31–2026-09-29
-11.7%42.5%96.7%150.9%205.1%259.3%Jul 17Oct 19Feb 22Jun 24Sep 26

Sponsored links

Advertisement